KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Realty Trust (HR) Cash from Financing Activities (2016 - 2025)

Healthcare Realty Trust (HR) has 16 years of Cash from Financing Activities data on record, last reported at -$676.1 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 31.54% year-over-year to -$676.1 million; the TTM value through Dec 2025 reached -$1.2 billion, up 10.94%, while the annual FY2025 figure was -$1.2 billion, 10.94% up from the prior year.
  • Cash from Financing Activities reached -$676.1 million in Q4 2025 per HR's latest filing, down from -$322.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $175.4 million in Q2 2021 and bottomed at -$1.7 billion in Q3 2022.
  • Average Cash from Financing Activities over 5 years is -$249.3 million, with a median of -$155.8 million recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: soared 737.04% in 2021, then tumbled 1896.74% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $132.6 million in 2021, then crashed by 364.88% to -$351.2 million in 2022, then dropped by 3.34% to -$363.0 million in 2023, then plummeted by 41.62% to -$514.0 million in 2024, then crashed by 31.54% to -$676.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$676.1 million in Q4 2025, -$322.2 million in Q3 2025, and -$160.2 million in Q2 2025.